**Core tip:** Zika virus is gaining new ground with the recent outbreaks that are starting to expand worldwide. While normally transmitted by the mosquito, other routes of transmission are being discovered. Also, other medical complications are being detected with Zika virus infections. These recent findings require the scientific community to thoroughly examine Zika virus to better understand it so that better diagnostic options, treatment, and preventative measures can be developed. In order to beat Zika virus, we must understand its history and outbreak patterns as well as gain a full understanding of all clinical manifestations associated with this virus.

INTRODUCTION
============

The Zika virus, together with the West Nile virus, Yellow fever virus, Japanese encephalitis virus, Dengue fever virus, and many other classified and unclassified viruses, forms the genus *Flavivirus* that belongs to family Flaviviridae. The family Flaviviridae consists of many other viruses that are summarized in a 2010 review\[[@B1]\]. This family of viruses have enveloped icosahedral capsid that contains a single strand RNA genome (about 11000 nucleotides) with positive sense\[[@B2]\]. Therefore, the infected viral RNA can be directly translated to a large polyprotein precursor, which is co- and post-translationally processed by viral and cellular proteases into structural and non-structural proteins. The three structural proteins are critical for the formation of envelop and capsid, and the seven non-structural (NS) proteins play important roles in virus replication. The three structural proteins are envelope, E; membrane precursor, PrM; and capsid, C. The seven NS proteins include NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5 (Figure [1](#F1){ref-type="fig"}). The names, location in the infected cells, and functions of viral proteins are listed in Table [1](#T1){ref-type="table"}. The members of the genus *Flavivirus* are characterized by similarities in genomic structure, viral protein function, pathogenesis and transmission.

###### 

Roles of viral protein and RNA during viral infection in permissive cells

  **Name of the vital material**                  **Location in cell**              **Function**
  ----------------------------------------------- --------------------------------- --------------------------------------------------------------------------------
  Viral genome + ssRNA (approximately 11000 nt)   Cytoplasm                         Template for protein translation and for viral genome replication
  Envelope, E (53 KDa)\[[@B52]\]                  Cell membrane                     Viral assembly, budding, attachment to target cells, and viral membrane fusion
  Membrane precursor, PrM (20 KDa)\[[@B53]\]      Cell membrane                     Facilitating E protein folding and trafficking, and virion maturation
  Capsid, C (12 KDa)\[[@B54]\]                    Cytoplasm                         Virion maturation
  NS1 (glycoprotein)\[[@B55]\] (46-55 kDa)        Endoplasmic reticulum             Subverting immune response
  vesicular compartments,                         virus-induced intracellular RNA   
  cell surface                                    replication, neurovirulence       
  NS2a (25 kDa)\[[@B56]\]                         Transmembrane                     Virus assembly, inhibit IFN-response
  NS2b (14 kDa)\[[@B1],[@B57]\]                   Cytoplasm, nucleus                Viral protein cleavage
  NS3 (69 kDa)\[[@B1]\]                           Cytoplasm, nucleus                Viral protein cleavage, RNA
  triphosphatase, mRNA capping,                                                     
  RNA helicase                                                                      
  NS4a (16 kDa)\[[@B58]\]                         Transmembrane                     Viral RNA replication
  NS4b (21.5 kDa)\[[@B59]\]                       Integral membrane                 Suppression of (IFN-α/β),
  suppression of the host RNAi,                                                     
  negatively regulate the helicase                                                  
  function, viral replication                                                       
  NS5 (103 kDa)\[[@B60],[@B61]\]                  Cytoplasm, nucleus                The RNA triphosphatase,
  RNA-dependent RNA polymerase                                                      

![Genomic structure and gene production of Flavivirus. AUG: Translation start codon; UAG: Translation stop codon; NCR: Non coding RNA sequence; kb: Kilo base; Aa: Amino acid.](WJV-6-1-g001){#F1}

The large polyprotein precursor must be cleaved to generate actively functional proteins. The cleavage of the polyprotein precursor is a sophisticated process and is completed collaboratively by cellular proteases of the PACE (Paired basic Amino acid Cleaving Enzyme)-type or other Golgi-localized proteases and the viral serine protease embedded in the N-terminal domain of non-structural protein 3 (NS3Pro), which requires NS2b for its activity\[[@B1]\]. A distinct feature of genus *Flavivirus* from other genera of Flaviviridae is that the 5′-end of the (+)ssRNA genome of genus *Flavivirus* is decorated with an RNA cap structure (N7meGpppA2′Ome-RNA). 5'end capping of the viral RNA is as important as that for eukaryotic mRNAs, not only to initiate the process of translation but also to protect the viral RNA from degradation by endogenous RNA exonucleases. The protein translation happens immediately after the uncoating of viral particle in the cytoplasm. The (+)ssRNA genome is used as a template not only for gene expression but also for viral genome replication. Both viral RNA replication and gene translation occur in the cytoplasm. For RNA replication, viral NS proteins and cellular proteins interact to form a replication compartment (RC). During the period of viral RNA replication in the cytoplasm, the RC consists of morphologically distinct, membrane-bound compartments that also differ with respect to both function and NS proteins composition\[[@B3]\]. The NS3 and NS5 proteins are central to the viral RC, as together, they harbor most, if not all, of the catalytic activities required to both cap and replicate the viral RNA. Following replication, the protected genomic RNA is packaged by the C protein to form a capsid in a host-derived lipid bilayer in which the E protein is embedded and later integrated into viral envelope. The mature particles subsequently exit from the host cell by exocytosis.

REGIONAL ISOLATION OF ZIKA VIRUS
================================

The Zika virus is phylogenetically close to *Spondweni* virus and a member of Flaviviridae family\[[@B4]\]. Comparative genomic analysis revealed that coding regions of pre-epidemic and epidemic strains of the Zika virus were similar with the exception of the NS2B. Bootscan analysis and multiple sequence alignment of the Asian lineage suggested that there may be genetic recombination of a fragment (nucleotides 4237-4528) of NS2B with that of the *Spondweni virus*\[[@B5]\].

African countries
-----------------

In 1947, a group of scientists from United Kingdom led by Haddow et al\[[@B4]\] who were investigating yellow fever isolated Zika virus from a rhesus macaque with fever in the Zika Forest in Uganda\[[@B6],[@B7]\]. The isolated viral strain has been stored in ATCC (ATCC^®^ VR84™, MR 766) and the European Virus Archive (France) and is now still used for studies. The next important step was to find out whether the Zika virus is transmitted by mosquitos. First, Boorman et al\[[@B8]\] demonstrated that Zika virus can infect and replicate in mosquitos, providing experimental evidence that Zika virus may be transmitted by mosquitos. Later, the United Kingdom *Flavivirus* research group continued their studies of arboreal mosquitos as virus vectors in Uganda. They isolated 12 strains of Zika virus from *Aedes (Stegomyia) africanus* in the Zika forest\[[@B9]\]. Zika virus is apparently enzootic in Zika forest, and the evidence collected by Hoddow et al\[[@B9]\] suggested that *Aedes africanus* is the primary vector and that forest-dwelling monkeys and human are, on occasion, involved. It was not clear whether the mosquito transmitted the virus to other animals because no small mammal trapped in the forest showed serum antibody against the Zika virus. The Zika virus infection in humans was first reported in 1954\[[@B10]\]. It has also been experimentally demonstrated *via* volunteers that the Zika virus is able to infect humans\[[@B11]\]. In summary, results from these investigations suggest that the Zika virus is an arbovirus, transmitted by mosquitos and infects at least monkeys and humans.

Southern Asian countries
------------------------

The first isolation of Zika virus in South-Eastern Asia was reported in 1969 in Malaysia\[[@B12]\]. Some years later, there was another report that the Zika virus was isolated from patients in Indonesia\[[@B13]\]. The event occurred during the end of the rainy season of 1977 when *Aedes aegypti* usually flourishes. Seven patients in central Java, Indonesia, appeared in the hospital with high fever, malaise, stomach ache, dizziness and anorexia. Data on these 7 Zika virus cases and several previously reported human infections indicated that clinical characteristics of infection with Zika virus appeared relatively mild, self-limiting, and nonlethal. It was suspected that the virus was transmitted by *Aedes aegypti*, which had been reported to be a probable vector in Malaysia\[[@B12]\]. A later investigation in Sabah, Malaysia, showed that the Zika virus infected 60 semi-captive and 84 free-ranging orangutans (Pongo pygmaeus pygmaeus)\[[@B14]\]. Another study conducted by the United States Naval Medical Research Unit No. 2 (NAMRU-2) isolated Zika virus in Cambodia in 2010\[[@B15]\]. This case was from a 3-year-old boy who had 4 d of fever, sore throat and cough as well a headache that lasted for 3 d. The studies conducted in southern Asia further confirmed that mosquitos are the vector and the primates might be the end host of viral infection.

The Zika virus has been also isolated from animals and human in other African countries. For examples, during the years 1964 to 1970, Moore et al\[[@B16]\] isolated 171 arboviruses of 15 different types from humans in Ibadan, Nigeria. Zika virus isolation rates also varied by season, with peaks in rainy seasons (June to August) and lows in dry seasons (January to February). Viruses were isolated from all age groups, with the majority from children one to four years old. The viruses isolated in largest numbers were chikungunya and yellow fever, which caused epidemics in 1969, and dengue types 1 and 2 and Tataguine, which are endemic in Ibadan. The Zika virus was isolated at a low rate. In 1999, three strains of the Zika virus were isolated as part of yellow fever studies in the Ivory Coast\[[@B17]\]. In 2010, it was reported that the Zika virus was isolated at a high rate in Cameroon. The research group investigated 102 sera from febrile patients (with negative laboratory findings for malaria and typhoid fever) at clinics in the Fako Division of Cameroon. The Zika virus was isolated at a rate of 11.4%, higher than that of any other members of Genus *Flavivirus*\[[@B18]\]. Therefore, following the time, the Zika virus has been spread throughout Africa.

More and more Zika virus strains have been isolated from humans worldwide\[[@B17]\]. Studies conducted in Nigeria during 1971-1975 isolated the Zika virus from humans. Serological experiments showed that 40% of the persons tested had neutralizing antibody to the Zika virus\[[@B16],[@B19]\]. The infected populations were detected in other African countries such as Uganda, Tanzania, Egypt, Central African Republic, Sierra Leone, and Gabon, and in parts of Asia, including India, Malaysia, the Philippines, Thailand, Vietnam, and Indonesia\[[@B20]\]. Table [2](#T2){ref-type="table"} lists the strains that have been sequenced. The data from the viral genomic analysis support the hypothesis that the Zika viruses can be classified by origin into the Southern-Eastern Asian type and African type (Table [2](#T2){ref-type="table"}). Other isolates might be derived from these types.

###### 

Origin of the types Zika viruses

  **Isolation region**   **Isolation year**   **Accession \#**   **Strain**                       **Ref**.
  ---------------------- -------------------- ------------------ -------------------------------- ---------------------------
  Malaysia               1966                 HQ234499           P6-740                           Haddow et al\[[@B4]\]
  Micronesia             2007                 EU545988           N/A                              Lanciotti et al\[[@B23]\]
  Cambodia               2010                 JN860885           FSS13025                         Haddow et al\[[@B4]\]
  Thailand               2016                 KU681082           H.sapiens-tc/PHL/2012/CPC-0740   unpublished
  Philippines            2016                 KU681081           H.sapiens-tc/THA/2014/SV0127     unpublished
  China                  2016                 KU744693           VE Ganxian                       unpublished
  China                  2016                 KU740184           GD01                             unpublished
  Nigeria                1968                 HQ234500           IBH 30656                        Haddow et al\[[@B4]\]
  Senegal                1984                 HQ234501           ArD 41519                        Haddow et al\[[@B4]\]
  Uganda                 1947                 HQ234498           MR766                            Haddow et al\[[@B4]\]
  Uganda                 2004                 NC012532           N/A                              Kuno et al\[[@B62]\]
  CAR                    2014                 KF268948           ARB13565                         Berthet et al\[[@B63]\]
  CAR                    2014                 KF268949           ARB15076                         Berthet et al\[[@B63]\]
  CAR                    2014                 KF268950           ARB7701                          Berthet et al\[[@B63]\]
  Senegal                2001                 KF383119           ArD158084                        Faye et al\[[@B2]\]
  Senegal                2001                 KF383118           ArD157995                        Faye et al\[[@B2]\]
  Senegal                2001                 KF383117           ArD128000                        Faye et al\[[@B2]\]
  Senegal                2001                 KF383116           ArD7117                          Faye et al\[[@B2]\]
  Brazil                 2016                 KU497555           Brazil-ZKV2015                   Calvet et al\[[@B64]\]
  Brazil                 2016                 KU707826           SSABR1                           Costa et al\[[@B65]\]
  Brazil                 2016                 KU527608           Natal RGN                        Mlakar et al\[[@B48]\]
  Brazil                 2016                 KU501215           PRVABC59                         Lanciotti et al\[[@B23]\]
  Brazil                 2016                 KU321639           ZikaSPH2015                      Staples et al\[[@B66]\]
  Brazil                 2016                 KU312312           Z1106033                         Enfissi et al\[[@B67]\]
  France                 2014                 KJ776791           H/PF/2013                        Baronti et al\[[@B68]\]
  Martinique             2016                 KU647676           Martinique_PaRi_2015             Baronti et al\[[@B68]\]
  Haiti                  2014                 KU509998           Haiti/1225/2014                  Lednicky et al\[[@B69]\]

CAR: Central African Republic; N/A: Not applicable.

ZIKA VIRUS OUTBREAKS AND CLINICAL COMPLICATIONS
===============================================

The Zika virus has been considered as a benign pathogen, causing asymptomatic or mild infections. Currently, there is no serological test that can clearly distinguish the Zika virus from other *Flaviviruses*. Diagnostic tests for Zika include RT-PCR, an IgM ELISA, and a plaque reduction neutralization test (PRNT). Some commercial tests have only become recently available\[[@B21]\]. Even a report from Olson et al\[[@B13]\] in 1981 that a cluster of 7 people with serologic evidence of the Zika virus illness in Indonesia did not attract serious attention and was not considered an outbreak due to the mildness of the associated illness. Later on, the same arbovirus research group performed a serological study that showed that 9/71 (13%) human volunteers in Lombok, Indonesia, had neutralizing antibodies to the Zika virus\[[@B22]\]. However, no serious cases were reported. The first outbreak of Zika virus-caused diseases was reported in 2007 on Yap Island of Micronesia. In April 2007, physicians on Yap Island characterized the disease with rash, conjunctivitis, arthralgia, arthritis, and fever. The disease affected 99 patients in 2 mo. A comprehensive study that combined analysis of patient samples, serological testing and real-time RT-PCR revealed the genetic and serological properties of the Zika virus epidemic\[[@B23]\]. The studies suggested that the 2007 Yap Island Zika virus is distantly related to African subclades and may be spread from Southeast Asia and the Pacific. Duffy et al\[[@B24]\] later conducted an extensive study on the Yap Island Zika virus outbreak. From 185 patients, 49 had been confirmed with the Zika virus illness, only 5 were excluded from Zika virus infection, and all others were suspected of Zika virus infection. They used survey studies in a large population, and estimated that 73% of the population of the Yap Island was infected with the Zika virus during the epidemic outbreak. Therefore, the outbreak on Yap Island in 2007 suggested that Zika virus infection has been spread outside of Africa and Asia\[[@B17]\]. Of course, whether or not the Zika virus was imported from Africa or Asia or other places remains to be verified.

Another Zika outbreak occurred between Oct. 2013 and Feb. 2014 in French Polynesia - like Yap Island, another island in the Pacific Ocean. In the very beginning of the outbreak, a mild dengue-like illness was observed in the patients within a family (consisting of wife, husband and their son-in-law). The symptoms included low fever (\< 38 °C), asthenia, wrist and fingers arthralgia, headache, rash, and conjunctivitis. The RT-PCR test confirmed that it was a Zika virus infection\[[@B25]\]. The epidemic has been spread to a large population as reported by the syndromic surveillance network (6630 suspected Zika virus infection cases), 333 of which were confirmed by real-time RT-PCR as Zika virus infections. Symptoms of most Zika virus infection cases are mild and self-limited (mean duration of symptoms is 3-6 d)\[[@B25]-[@B27]\]. No hospitalizations for acute infection have been reported. In contrast to the outbreak in Yap Island, some severe complications were seen in this outbreak: The first case of Guillain-Barré syndrome (GBS) was found immediately after a Zika virus infection\[[@B28]\], and another case of vertical transmission from an infected pregnant woman to the baby was reported in this outbreak\[[@B29]\].

The spread of Zika virus from the outbreak of French Polynesia has been reported. Two Japanese travelers were confirmed to be infected with the Zika virus after they returned from a trip to French Polynesia during the time of the outbreak\[[@B30]\]. In addition, it was found to have spread to other Pacific Islands including New Caledonia, Cook Islands, Easter Island, Vanuatu, and Solomon Islands\[[@B31]\]. The introduction of the Zika virus from French Polynesia into New Caledonia caused another outbreak in New Caledonia in 2014\[[@B32]\]; The first cases of Zika virus infection were confirmed in November 2013, and they were imported from French Polynesia. By the end of 2014, a total of 1383 cases were confirmed in a laboratory\[[@B32]\]. Consequently, an outbreak in New Caledonia was declared. Thus far, introduction of the Zika virus from French Polynesia to other countries has been continuously reported.

Between 1947 and 2006, \< 20 cases of Zika virus infection have been reported\[[@B5]\]. There have been recent reports of imported cases of Zika virus infections in 18 travelers returning to the Netherlands from Surinam, which is in South America near the northern border of Brazil, and the Dominican Republic\[[@B33]\], 13 infections were imported from Venezuela, Fiji/Samoa, or Suriname to China\[[@B34]\], and 4 infections were imported from Brazil to Portugal\[[@B35]\]. Autochthonous cases were reported in places such as Mexico\[[@B36]\], Colombia\[[@B37]\], and Easter Island, which was the first outbreak (51 cases) reported in a territory of the Americas in early 2014\[[@B38]\].

The recent outbreak in Brazil has attracted the most attention due to not only its growing infected population but also its likely enhanced severity of the clinical sequelae. In March of 2015, Zanluca et al\[[@B39]\] from the Molecular Virology Laboratory of Carlos Chagas Institute, Oswaldo Cruz Institute, state of Paraná, Brazil, detected the Zika virus genome by RT-PCR from 8 out of 21 acute-phase serum specimens from the patients with dengue-like symptoms. This is the first report of Zika virus outbreak in Brazil. Later, another group reported a similar detection of Zika virus cases (8 out 24 samples) by RT-PCR\[[@B40]\]. The virus has been assumed to have been imported from French Polynesia either by the travelers during the time of the World Cup\[[@B39]\] or by the teams from the Va'a World Sprint Championship canoe race that was held in Rio de Janeiro, Brazil\[[@B41]\]. It has been reported that the virus is carried by the travelers to other countries\[[@B42]\]. Genomic sequencing has been conducted to analyze the similarities between different strains isolated historically. Phylogenetic studies showed that the Brazilian strain is closely related to the one from French Polynesia, and the French Polynesia strain is likely derived from Yap Island. These strains all belong to the Asian lineage\[[@B41]\].

The severe clinical sequelae caused by Zika virus infection include the following. First, during the outbreak of the Zika virus in French Polynesia, the Zika virus was detected from the semen of a patient, which brought out the presumption that the Zika virus might be transmitted sexually\[[@B43]\]. Several cases of Zika virus infected patients have been reported to be sexually transmitted\[[@B44]\]. This observation implies another transmission route for the Zika virus other than through mosquito. Secondly, the Zika virus was reported to be transmitted vertically (from the infected mother to the fetus). This is a major problem for patients infected by Zika virus because the virus directly results in birth defects. Again, the first cases of congenital Zika virus infection were found during the French Polynesia outbreak\[[@B29]\]. Thirdly, it was reported to be related to some severe syndromes like GBS\[[@B28],[@B45]\]. In addition, Zika virus infection might have been associated with microcephaly\[[@B46]-[@B51]\]. However, after more detailed and accurate experimental studies and clinical analysis, the number of Zika-related microcephaly dropped quickly. Therefore, all the linkages to the severe diseases are still informative not conclusive. Systemic research in different aspects for Zika virus is needed to assure that the clinical findings are explained and understood.

FUTURE DIRECTIONS
=================

Even though the world has noticed the emergence of Zika virus infection, time is needed to achieve understanding of its pathogenesis, prevention, and treatment. A previously systemic study is lacking, so the Zika virus, from now on, will be another member of Genus *Flavivirus* to be the center of virological research. The following aspects may be very important in the near future: Animal model for Zika virus infection: It will help researchers understand whether and how Zika virus causes neural disorder through interfering with the neural progenitor cell/neural stem cell (NPC/NSC) proliferation and differentiation; vaccine development: Like all other viruses, the best and most effective way to prevent viral infection is by vaccine. Some successful experience in Dengue virus and yellow fever virus may be useful towards developing the Zika vaccine; transmission prevention. Viral transmission needs to be studied, such as whether and how semen components enhance viral infection.
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